Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide for cerebrospinal fluid leak after incidental durotomy in lumbar spine surgery
PACTR202611481023113Phase 3Unknown
- Sponsor
- Ain Shams University Faculty of Medicine
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of acetazolamide in cerebrospinal fluid leak (2 arms), sponsored by Ain Shams University Faculty of Medicine. Primary endpoint: Time to complete resolution of cerebrospinal fluid leak. Status: unknown.
02
Drugs
acetazolamide
03
Conditions
cerebrospinal fluid leak
Beyond the preview
Go deeper on PACTR202611481023113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202611481023113.